Development of a screening and treatment program using oral ivermectin to manage pediculosis capitis (head lice) in primary schools

Phase 4

• Conditions: Head lice infestation; Public Health - Health service research; Skin - Dermatological conditions; Public Health - Health promotion/education

• Registration Number: ACTRN12611000906954
• Lead Sponsor: Australian National University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-08-24
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

Consented/consenting Australian Capital Territory primary school students and their household members (screening)

Consented/consenting Australian Capital Territory primary school students and their household members who are infested with head lice (treatment)

Exclusion Criteria

Children aged less than 5 years
Children weighing less than 15 kilograms
Pregnant women
Breast feeding women
People reporting allergic reaction or hypersensitivity to ivermectin or any of the components of Stromectol e.g gluten
Students who do not verbally ASSENT to participation

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The prevalence of head lice infestation in primary schools students infested/hyperinfested with head lice and their infested/hyperinfested household members are treated with oral ivermectin. Outcome is measured by clinical assessment of all consented primary school students by trained head lice screeners in schools where ivermectin treatment has been offered 3 months after treatment.[3 months]